ivabradine has been researched along with Sclerosis, Systemic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biase, MD; Brunetti, ND; Correale, M; Montrone, D | 1 |
| Brunetti, ND; Correale, M; Di Biase, M; Ieva, R; Montrone, D | 1 |
2 other study(ies) available for ivabradine and Sclerosis, Systemic
| Article | Year |
|---|---|
Safe and well-tolerated treatment with ivabradine in systemic sclerosis affected by pulmonary hypertension.
Topics: Anti-Arrhythmia Agents; Antihypertensive Agents; Benzazepines; Cardiac Catheterization; Drug Therapy, Combination; Echocardiography, Doppler; Exercise Test; Exercise Tolerance; Familial Primary Pulmonary Hypertension; Female; Heart Rate; Humans; Hypertension, Pulmonary; Ivabradine; Middle Aged; Pulmonary Artery; Pulmonary Wedge Pressure; Scleroderma, Systemic; Time Factors; Treatment Outcome | 2012 |
Ivabradine in systemic sclerosis related pulmonary arterial hypertension.
Topics: Aged; Benzazepines; Familial Primary Pulmonary Hypertension; Female; Heart Failure; Humans; Hypertension, Pulmonary; Ivabradine; Middle Aged; Scleroderma, Systemic; Treatment Outcome | 2012 |